Want to join the conversation?
As part of the agreement, $BDX will distribute the Check-Direct CPE Screen for the BD MAX assay outside of the US while Check-Points will maintain exclusivity in the Netherlands. Check-Points and $BDX also plan to develop and commercialize a next-generation CRO assay for launch outside the US in 2017 and in the US at a later time.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?